MENU
FBT
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

FBT stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index... Show more

Category: #Health
FBT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for FBT with price predictions
Oct 01, 2026

FBT's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for FBT moved out of overbought territory on August 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 instances where the indicator moved out of the overbought zone. In 22 of the 26 cases the stock moved lower in the days that followed. This puts the odds of a move down at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 52 of 64 cases where FBT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FBT as a result. In 67 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

The Moving Average Convergence Divergence Histogram (MACD) for FBT turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 41 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

Bullish Trend Analysis

Following a +2.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where FBT advanced for three days, in 296 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

FBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 244 of 272 cases where FBT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Illumina (NASDAQ:ILMN), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Market Cap

The average market capitalization across the First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF is 38.5B. The market cap for tickers in the group ranges from 1.99B to 226.05B. AMGN holds the highest valuation in this group at 226.05B. The lowest valued company is SRPT at 1.99B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF was 14%. For the same ETF, the average monthly price growth was 28%, and the average quarterly price growth was 286%. UTHR experienced the highest price growth at 21%, while NEO experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF was 4%. For the same stocks of the ETF, the average monthly volume growth was 11% and the average quarterly volume growth was -12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 69
P/E Growth Rating: 44
Price Growth Rating: 43
SMR Rating: 60
Profit Risk Rating: 63
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
FBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
First Trust Exchange-Traded Fund1001 Warrenville Road, Suite 300Lisle
Phone
630-241-4141
Web
www.ftportfolios.com